Location of Repository

Sites, Staff and Infrastructure for Clinical Trials in Mexico and Latin America Abstract

By Gabriela Mancera M. D and Quintiles Mexico

Abstract

The number of clinical trials performed in Latin America has been increasing over the past years due to our regional characteristics. The worldwide economy slowed down during the 90’s through the beginning of 2002. Some countries underwent economical crisis and currency devaluation, and an integral health system conformation was far from being a fact. This situation, plus the conventional concept of developing countries environment, and former negative experiences, caused sponsors hesitation to conduct clinical trials among Latin America. Many characteristics and advantages make Latin America an attractive region for clinical research, such as: � Increasing frequency of chronic and infectious illness, making it possible to conduct clinical trials in both diseases groups. � Mega cities (Mexico City, Buenos Aires, and Sao Paulo) with large concentration of patients, either in specialty or large general public hospitals. � Blended population of different backgrounds. � Growing experience in GCP and ICH norms

Year: 2011
OAI identifier: oai:CiteSeerX.psu:10.1.1.198.538
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://citeseerx.ist.psu.edu/v... (external link)
  • http://www.quintiles.com/NR/rd... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.